Condition deep-dive · 10 min read

PCOS supplement protocol — what the 2025 evidence supports

Updated 2026-05-02 · Reviewed by SupplementScore editors · No sponsorships

Polycystic ovary syndrome is the single most common endocrine disorder in people with ovaries — and one of the most heavily marketed-to populations in the supplement industry. Most "PCOS support" products are kitchen-sink combinations with no protocol behind them. The actual evidence base is narrower than the shelf would suggest, but for two metabolic targets in particular it is genuinely robust.

Read this first. Supplements complement, but do not replace, a PCOS care plan. The first-line metabolic intervention for most patients remains weight management and metformin where indicated; the first-line reproductive interventions remain combined oral contraceptives, anti-androgens, and ovulation induction. Talk to a clinician, ideally one with a PCOS focus, before adding any supplement at trial-validated doses — particularly if you are pregnant, planning pregnancy, or on metformin.

The four with the strongest evidence

Tier 1 evidence · Insulin sensitivity + ovulation

Inositol (myo + D-chiro, 40:1 ratio)

2 g myo-inositol + 50 mg D-chiro-inositol, twice daily — total 4 g + 100 mg/day

The single best-evidenced supplement intervention for PCOS. Multiple meta-analyses now confirm improvements in insulin resistance (HOMA-IR), menstrual regularity, ovulation rates, and androgen markers at the 40-to-1 myo-to-D-chiro ratio that mirrors the natural ovarian ratio. Effect sizes for menstrual regularity are comparable to metformin in head-to-head trials, with substantially better gastrointestinal tolerance. Onset of metabolic effect is roughly 8 weeks; ovulatory effect typically 12 to 24 weeks. Generally well tolerated; rare GI upset at higher doses.

Tier 1 evidence · If deficient · Foundation

Vitamin D3

2,000–4,000 IU/day with a fatty meal; check 25-OH-D before and at 8 weeks

Vitamin D deficiency is more common in PCOS than in matched controls, and observational associations between low vitamin D and worse PCOS metabolic markers are consistent. Repletion improves insulin sensitivity, reduces inflammatory markers, and modestly improves menstrual regularity in deficient patients. Test first — supplementing in someone already replete shows minimal benefit. Pair with K2 if you're also supplementing calcium.

Tier 2 evidence · Insulin sensitivity + lipids

Berberine

500 mg, three times daily with meals

An alkaloid that activates AMP-activated protein kinase, with metformin-comparable effects on fasting glucose and HOMA-IR in head-to-head PCOS trials. Also reduces total and LDL cholesterol and waist-hip ratio. Effects on androgens and menstrual regularity are smaller and less consistent than the metabolic effects. Caution: berberine inhibits CYP3A4 and P-gp meaningfully — talk to a pharmacist about any prescription medication, particularly ciclosporin, tacrolimus, statins, and DOACs. Avoid in pregnancy.

Tier 2 evidence · Hirsutism + androgen markers

Spearmint tea

2 cups (about 250 mg leaf each) daily, brewed for 5–10 min

Sounds folkloric but actually has small but reproducible randomised-trial support. Two cups of spearmint tea daily over 30 days reduces free testosterone and modestly improves Ferriman–Gallwey hirsutism scores in PCOS patients. Effect size is smaller than spironolactone or oral contraceptives, but the side-effect profile is essentially zero. Reasonable as an adjunct, not a primary anti-androgen treatment. The effect is on free testosterone via SHBG modulation — mechanism is partially understood, partially not.

What about the others

N-acetylcysteine (NAC)

Some positive PCOS trials, particularly for insulin sensitivity and ovulation. Effect sizes are smaller than inositol or berberine, and the evidence base is older and less consistent. Reasonable to add at 600 mg twice daily if first-line interventions are insufficient. Generally well tolerated. Clear interactions with nitroglycerin and theoretical interactions with anticoagulants.

Omega-3 fatty acids

Modest improvements in androgens, lipids, and inflammatory markers in PCOS trials at 1 to 2 g/day combined EPA + DHA. Not specifically a PCOS treatment, but worth including if you don't already eat oily fish twice weekly. Mind the high-dose AFib paradox if you're using over 1 g/day long-term — see our EPA vs DHA vs ALA comparison.

Chromium

Small effect on insulin sensitivity in some PCOS trials, but effect size is much smaller than inositol or berberine. Reasonable supportive role at 200 to 400 mcg/day if metabolic markers are stuck despite the primary protocol.

Magnesium

Magnesium status is often low in PCOS and supports insulin signalling. Not a PCOS-specific treatment, but a reasonable foundational nutrient. Glycinate at 300 mg/day is a sensible default.

What to skip

"PCOS-specific" multivitamin complexes — typically combine inositol, berberine, vitamin D, and others at sub-therapeutic doses for marketing convenience. Buying ingredients separately at trial-validated doses costs less and works better.
Saw palmetto — marketed for hirsutism on the basis of male androgenetic alopecia data. PCOS-specific evidence is essentially absent.
DHEA — used in some adjuvant fertility protocols but should never be self-prescribed in PCOS, which is already characterised by androgen excess.
"Detox" or "liver cleanse" formulas — no PCOS evidence. The kidneys and liver are not the bottleneck.
High-dose biotin — popular for hair changes but interferes with thyroid lab assays — can cause falsely abnormal TSH and free-T4 readings, which complicates PCOS workup.

Sequencing the protocol

Recommended order: start with vitamin D (after testing) and inositol, both for 12 weeks. Re-assess metabolic markers (HOMA-IR or fasting insulin), menstrual regularity, and any androgen-related symptoms. If insulin resistance persists, add berberine. If hirsutism persists, add spearmint tea. NAC and chromium come in only if Layer 1 plus 2 are insufficient.

Practical quick-start. Inositol 2 g + D-chiro 50 mg twice daily, plus vitamin D3 2,000 IU daily, plus magnesium glycinate 300 mg evenings — for 12 weeks before reassessing. This single combination addresses the two metabolic levers with the strongest evidence and the lowest interaction risk.

What to track

Useful objective markers: HOMA-IR (calculated from fasting glucose and insulin), free and total testosterone, SHBG, AMH (less reliable for change tracking), 25-OH vitamin D, menstrual cycle length, and Ferriman–Gallwey score for hirsutism. Re-test the labs at baseline and at 12 weeks; track menstrual cycles and any visible hirsutism continuously.